FELEK, R. Et Al. 2005. Polymorphism in the TNF-Alpha gene promoter at position-1031 is associated with increased circulating levels of TNF-Alpha, myeloperoxidase and nitrotyrosine in primery Sjogren’s syndrome. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.30 , 843-849.

FELEK, R., AYDIN ASLAN, M., doğan, s., Sezer, İ., & Çay, H., (2005). Polymorphism in the TNF-Alpha gene promoter at position-1031 is associated with increased circulating levels of TNF-Alpha, myeloperoxidase and nitrotyrosine in primery Sjogren’s syndrome. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.30, 843-849.

FELEK, RASİH Et Al. "Polymorphism in the TNF-Alpha gene promoter at position-1031 is associated with increased circulating levels of TNF-Alpha, myeloperoxidase and nitrotyrosine in primery Sjogren’s syndrome," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.30, 843-849, 2005

FELEK, RASİH Et Al. "Polymorphism in the TNF-Alpha gene promoter at position-1031 is associated with increased circulating levels of TNF-Alpha, myeloperoxidase and nitrotyrosine in primery Sjogren’s syndrome." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.30, pp.843-849, 2005

FELEK, R. Et Al. (2005) . "Polymorphism in the TNF-Alpha gene promoter at position-1031 is associated with increased circulating levels of TNF-Alpha, myeloperoxidase and nitrotyrosine in primery Sjogren’s syndrome." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.30, pp.843-849.

@article{article, author={RASİH FELEK Et Al. }, title={Polymorphism in the TNF-Alpha gene promoter at position-1031 is associated with increased circulating levels of TNF-Alpha, myeloperoxidase and nitrotyrosine in primery Sjogren’s syndrome}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2005, pages={843-849} }